Bruker to hold NMR webinar in late November

One of the world's leading analytical instrumentation companies is presenting an educational webinar on nuclear magnetic resonance (NMR) later this month.

Bruker is holding the online event to offer insight into the relevance of NMR to health related questions, diagnostic applications and treatment decisions.

Bruker are now inviting people to register for the online event, which is taking place on Wednesday 27th November and is free of charge.

Both increased life expectancy and changes in lifestyle habits have led to an increased need for healthcare providers to offer improved diagnostic tools that can enable early disease prediction and accurate recognition of disease stages as well as predicting treatment outcome in patients.

Instruments are also needed to assist in the individualized treatment of patients as well as being suitable for phenotyping populations to establish overall trends in disease susceptibility.

In the upcoming seminar, NMR applications expert Dr. Manfred Spraul will explain how the NMR approach provides a valuable tool for addressing some of these challenges.

NMR can generate results at the touch of a button and can also be combined with integrated data analysis techniques to provide detailed reports for physicians to interpret, for example.

NMR also provides a highly reproducible and reliable approach that can operate in conditions of high throughput and across a wide range of health or disease related parameters in the analysis of both body fluids and body tissues.

Following the main presentation, metabolomics and systems biology expert Dr Claire Cannet will be hosting a question and answer session.

The seminar which is entitled “NMR based translational research to develop in vitro diagnostic routines,” is available in two sessions which will start at 10.00 am and 5.00 pm CET time.

Individuals who are unable to attend the event are given the opportunity to register anyway and have the webinar slides and a link to a recording of the event sent to them for viewing at a more convenient time.

Register now to Session 1 (10:00 AM CET) or Session 2 (5:00 PM CET) .

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bruker BioSpin - NMR, EPR and Imaging. (2013, November 12). Bruker to hold NMR webinar in late November. News-Medical. Retrieved on May 10, 2024 from https://www.news-medical.net/news/20131105/Bruker-to-hold-NMR-webinar-in-late-November.aspx.

  • MLA

    Bruker BioSpin - NMR, EPR and Imaging. "Bruker to hold NMR webinar in late November". News-Medical. 10 May 2024. <https://www.news-medical.net/news/20131105/Bruker-to-hold-NMR-webinar-in-late-November.aspx>.

  • Chicago

    Bruker BioSpin - NMR, EPR and Imaging. "Bruker to hold NMR webinar in late November". News-Medical. https://www.news-medical.net/news/20131105/Bruker-to-hold-NMR-webinar-in-late-November.aspx. (accessed May 10, 2024).

  • Harvard

    Bruker BioSpin - NMR, EPR and Imaging. 2013. Bruker to hold NMR webinar in late November. News-Medical, viewed 10 May 2024, https://www.news-medical.net/news/20131105/Bruker-to-hold-NMR-webinar-in-late-November.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bruker’s molecular phenomics research tools enable new insights into ‘long COVID’ and post-acute metabolic abnormalities